NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 150)
Posted On: 01/24/2019 5:08:33 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Record Number of Scientific Papers Citing Benefits of its PCT Platform
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences industry, this morning announced worldwide publication by independent researchers of more than 20 scientific papers in 2018 citing advantages of the company’s pressure cycling technology (“PCT”) platform. The publications, authored by scientists from industry, government and academia (a number of which are key opinion leaders in their field) provided a wide range of applications for PBIO’s patented PCT Platform in cancer research, biomarker discovery, food safety, and proteomic and molecular biology studies. “We know that scientists have a strong tendency to rely heavily on data and opinions from colleagues and other experts in their field,” PBIO’s Global Director of Sales and Marketing Roxana McCloskey stated in the news release. “We therefore enhanced our marketing efforts during the second half of 2018 with a concerted effort to forward this large number of scientific publications to our base of existing and potential customers. We were pleased to see this effort result in increased interest and sales of our Barocycler instruments in 2018, which we believe will continue into 2019 as well.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences industry, this morning announced worldwide publication by independent researchers of more than 20 scientific papers in 2018 citing advantages of the company’s pressure cycling technology (“PCT”) platform. The publications, authored by scientists from industry, government and academia (a number of which are key opinion leaders in their field) provided a wide range of applications for PBIO’s patented PCT Platform in cancer research, biomarker discovery, food safety, and proteomic and molecular biology studies. “We know that scientists have a strong tendency to rely heavily on data and opinions from colleagues and other experts in their field,” PBIO’s Global Director of Sales and Marketing Roxana McCloskey stated in the news release. “We therefore enhanced our marketing efforts during the second half of 2018 with a concerted effort to forward this large number of scientific publications to our base of existing and potential customers. We were pleased to see this effort result in increased interest and sales of our Barocycler instruments in 2018, which we believe will continue into 2019 as well.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)